title: Lack of associations between serum leptin, a polymorphism in the gene for the beta 3-adrenergic receptor and glucose tolerance in the Dutch population.
abstract: BACKGROUND
  The associations between leptin levels and the prevalence of a polymorphism in the beta 3-adrenergic receptor were studied in a cross-sectional analysis of 600 participants in a population-based study, which were stratified for glucose tolerance by an oral glucose tolerance test.
  
  
  METHODS
  In a random sample of 600 participants in the Rotterdam study, aged 55-75 years at baseline (309 men, 291 women) the relationships were studied between the presence of Trp64 Arg mutation in the beta 3-adrenergic receptor gene and fasting leptin, glucose and insulin (fasting and after an oral glucose load), and other components of the insulin resistance syndrome.
  
  
  RESULTS
  Mean age of the study population was 66.9 years (SD 5.7). Fasting serum leptin levels overall in men and women were 6.1 micrograms/l (SE 0.2) and 21.7 micrograms/l (0.9), respectively, (P < 0.001). These differences were independent of age, body mass index and waist to hip ratio. We identified 73/600 persons who were heterozygotes for the Trp64 Arg polymorphism (allelic frequency 6.1%), but failed to find an association between the presence of this polymorphism and leptin or any measured parameter indicative for obesity, impaired glucose tolerance or type 2 diabetes mellitus.
  
  
  CONCLUSIONS
  Heterozygosity for the Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not accompanied by obesity, impaired glucose tolerance and type 2 diabetes mellitus in the general elderly Dutch population, and is also not associated with changes in circulating leptin levels.
authors.affiliation: Department of Internal Medicine III, Erasmus University, Rotterdam, The Netherlands.
authors.forename: J A
authors.initials: JA
authors.lastname: Janssen
authors.forename: J W
authors.initials: JW
authors.lastname: Koper
authors.forename: R P
authors.initials: RP
authors.lastname: Stolk
authors.forename: P
authors.initials: P
authors.lastname: Englaro
authors.forename: A G
authors.initials: AG
authors.lastname: Uitterlinden
authors.forename: Q
authors.initials: Q
authors.lastname: Huang
authors.forename: J P
authors.initials: JP
authors.lastname: van Leeuwen
authors.forename: W F
authors.initials: WF
authors.lastname: Blum
authors.forename: A M
authors.initials: AM
authors.lastname: Attanasio
authors.forename: H A
authors.initials: HA
authors.lastname: Pols
authors.forename: D E
authors.initials: DE
authors.lastname: Grobbee
authors.forename: F H
authors.initials: FH
authors.lastname: de Jong
authors.forename: S W
authors.initials: SW
authors.lastname: Lamberts
mesh_terms: D000368:Aged; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D005260:Female; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006579:Heterozygote; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics; D020738:Leptin; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D015995:Prevalence; D011506:Proteins / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3; D054411:Receptors, Leptin; D012044:Regression Analysis
chemical_list: C515448:LEPR protein, human; D020738:Leptin; D011506:Proteins; D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3; D054411:Receptors, Leptin; D005947:Glucose